Actively Recruiting
Turkish Version of the BRIEF-Hammersmith Infant Neurological Examination (HINE)
Led by Kahramanmaras Sutcu Imam University · Updated on 2025-09-19
120
Participants Needed
1
Research Sites
62 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The American Academy of Pediatrics defines high-risk infants as those with preterm birth, special health care needs, family risk factors, and those at risk of early death. Factors such as premature birth, perinatal asphyxia, hypoxic-ischemic encephalopathy (HIE), periventricular leukomalacia (PVL), intraventricular hemorrhage (IVH), chronic lung disease, seizures, meningitis, hyperbilirubinemia, twin/triplet pregnancy, and intrauterine growth restriction are risk factors that can result in morbidity and mortality in infants. Regular neurological examinations and neuromotor tests are necessary for at-risk infants to identify developmental problems early and to initiate early intervention programs.In developing countries, regular follow-up and early rehabilitation of at-risk infants are not successfully implemented. 5,6 The lengthy test batteries and busy clinics are among the most significant reasons. Therefore, the development and dissemination of shorter, valid, and reliable tests is of great importance. The Hammersmith Neonatal Neurological Examination (HINE), one of the gold standard methods, consists of 26 items and takes 15-20 minutes to administer.Due to the number of items and the duration, it is not frequently used routinely. In response to this clinical need, the HINE short scale was developed in 2024.The aim of the study is to have a Turkish version of the Abstract-HINE test in Turkey and to study its validity and reliability in high-risk infants.
CONDITIONS
Official Title
Turkish Version of the BRIEF-Hammersmith Infant Neurological Examination (HINE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Infants at high risk of cerebral palsy including those with periventricular hemorrhage, intracranial hemorrhage grade 2-4, cystic periventricular leukomalacia, stage 3 hypoxic ischemic encephalopathy, neonatal bilirubin encephalopathy, perinatal stroke, perinatal asphyxia, respiratory distress syndrome, bronchopulmonary dysplasia, and those needing long-term oxygen support
- Infants with sepsis caused by gram-negative bacteria or necrotizing enterocolitis
- Infants with infantile apnea or low 5-minute Apgar score of 3 or below
- Infants diagnosed with intrauterine growth retardation or multiple births (twins, triplets)
- Preterm infants with retinopathy of prematurity
- Infants with prolonged severe hypoglycemia or hypocalcemia
- Small for gestational age (below 3rd percentile) or large for gestational age (above 97th percentile) infants
- Infants who received mechanical ventilation for more than 24 hours
- Infants born at less than 32 weeks gestation or weighing less than 1500 grams
You will not qualify if you...
- Infants with any known orthopedic, systemic disease, or neurological diagnosis other than cerebral palsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kahramanmaraş Sütçü imam University
Kahramanmaraş, Onikişubat, Turkey (Türkiye), 46100
Actively Recruiting
Research Team
H
Hatice adıgüzel tat, Associate Proffessor
CONTACT
H
hatice Adiguzel tat, Associate Proffessor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here